News

Pfizer Inc. announced that Zavicefta, a novel combination antibiotic for the treatment of patients with certain confirmed or suspected Gram-negative bacterial infections requiring…
Read More...

Biocept, Inc., a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients,…
Read More...

AMO Pharma Limited, a privately held biopharmaceutical company focusing on debilitating diseases with limited or no treatment options, today announced it has entered a collaboration…
Read More...

Pfizer has launched Zavicefta (ceftazidime/avibactam), a combination antibiotic to treat Gram-negative bacterial infections requiring hospitalization, in the UK and Germany. Pfizer…
Read More...

Mylan N.V. announced that Mylan has agreed to the terms of a global settlement with Genentech, Inc. and F. Hoffmann-La Roche Ltd. in relation to patents for Herceptin® (trastuzumab),…
Read More...

Charles River Laboratories International, Inc., a leading early-stage contract research organization (CRO), today announced that it has extended its longstanding, strategic, integrated…
Read More...

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services, and Definiens, the leader in Tissue Phenomics® solutions from biomarker discovery to meaningful…
Read More...

Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology, is pleased to announce the successful initial…
Read More...

Mylan N.V., announced the U.S. launch of Desvenlafaxine Extended-release Tablets, 50 mg and 100 mg, a generic version of Pfizer's Pristiq® Tablets. Mylan received final approval from…
Read More...

BioreclamationIVT has acquired TransCell Science, a privately held contract research organization (CRO) specializing in the use of primary cells for phenotypic screening assays.  With…
Read More...

Pharnext SA, a French biopharmaceutical company developing an advanced portfolio of products in the field of neurodegenerative diseases, today announced a research and development…
Read More...

Amring Pharmaceuticals Inc., a generic pharmaceutical company, announced today that it acquired six ANDAs from Luitpold Pharmaceuticals, Inc. and AlphaForce, L.L.P., a joint venture…
Read More...

Apricus Biosciences, Inc., a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it completed the sale to Ferring International…
Read More...

Abeona Therapeutics Inc., a leading clinical-stage biopharmaceutical company focused on developing gene therapies for life-threatening rare diseases, announced today that the European…
Read More...

Kitov Pharmaceuticals Holdings Ltd., an innovative biopharmaceutical company, announced today that the Company has signed a definitive License Agreement for its lead product candidate,…
Read More...

Glenmark Pharmaceuticals, a global pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) cleared the Company's Investigational New Drug (IND) application to…
Read More...

Kasten, Inc. announced that it has completed a merger with Thru Pharma LLC dba DAKOTA Life Sciences. Upon review of Dakota during the phases of the JV setup, the Board of Directors and…
Read More...

BeiGene, Ltd. and Guangzhou Development District (GDD) announced that BeiGene (Hong Kong) Co., Ltd. (BeiGene HK), a wholly owned subsidiary of BeiGene, Ltd. and GDD and its affiliate…
Read More...

NuvOx Pharma announces that the first patients have been dosed in a Phase Ib/II clinical trial for NVX-208, an oxygen therapeutic being developed for acute ischemic stroke. The trial is…
Read More...

Vernalis plc and Servier are pleased to announce that they reinforce their partnership by entering into a new two-year oncology drug discovery collaboration on an undisclosed target.…
Read More...